{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T14:02:56Z","timestamp":1787061776384,"version":"build-2736575974"},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,11,15]],"date-time":"2018-11-15T00:00:00Z","timestamp":1542240000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2018,11,15]],"date-time":"2018-11-15T00:00:00Z","timestamp":1542240000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>CD8 T cells protect the liver against viral infection, but can also cause severe liver damage that may even lead to organ failure. Given the lack of mechanistic insights and specific treatment options in patients with acute fulminant hepatitis, we develop a mouse model reflecting a severe acute virus-induced CD8 T cell-mediated hepatitis. Here we show that antigen-specific CD8 T cells induce liver damage in a perforin-dependent manner, yet liver failure is not caused by effector responses targeting virus-infected hepatocytes alone. Additionally, CD8 T cell mediated elimination of cross-presenting liver sinusoidal endothelial cells causes endothelial damage that leads to a dramatically impaired sinusoidal perfusion and indirectly to hepatocyte death. With the identification of perforin-mediated killing as a critical pathophysiologic mechanism of liver failure and the protective function of a new class of perforin inhibitor, our study opens new potential therapeutic angles for fulminant viral hepatitis.<\/jats:p>","DOI":"10.1038\/s41467-018-07213-x","type":"journal-article","created":{"date-parts":[[2018,11,9]],"date-time":"2018-11-09T10:52:37Z","timestamp":1541760757000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":33,"title":["Perforin inhibition protects from lethal endothelial damage during fulminant viral hepatitis"],"prefix":"10.1038","volume":"9","author":[{"given":"M.","family":"Welz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Eickhoff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Z.","family":"Abdullah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7028-3881","authenticated-orcid":false,"given":"J.","family":"Trebicka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0343-1274","authenticated-orcid":false,"given":"K. H.","family":"Gartlan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J. A.","family":"Spicer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A. J.","family":"Demetris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H.","family":"Akhlaghi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Anton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.","family":"Manske","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.","family":"Zehn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B.","family":"Nieswandt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Kurts","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J. A.","family":"Trapani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Knolle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3861-5150","authenticated-orcid":false,"given":"D.","family":"Wohlleber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3835-1485","authenticated-orcid":false,"given":"W.","family":"Kastenm\u00fcller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,11,15]]},"reference":[{"key":"7213_CR1","doi-asserted-by":"publisher","first-page":"1266","DOI":"10.1172\/JCI33996","volume":"118","author":"BM Greenwood","year":"2008","unstructured":"Greenwood, B. M. et al. Malaria: progress, perils, and prospects for eradication. J. Clin. Invest. 118, 1266\u20131276 (2008).","journal-title":"J. Clin. Invest."},{"key":"7213_CR2","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1038\/nri1573","volume":"5","author":"B Rehermann","year":"2005","unstructured":"Rehermann, B. & Nascimbeni, M. Immunology of hepatitis B virus and hepatitis C virus infection. Nat. Rev. Immunol. 5, 215\u2013229 (2005).","journal-title":"Nat. Rev. Immunol."},{"key":"7213_CR3","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1146\/annurev.immunol.021908.132629","volume":"27","author":"IN Crispe","year":"2009","unstructured":"Crispe, I. N. The liver as a lymphoid organ. Annu. Rev. Immunol. 27, 147\u2013163 (2009).","journal-title":"Annu. Rev. Immunol."},{"key":"7213_CR4","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1038\/nri2858","volume":"10","author":"AW Thomson","year":"2010","unstructured":"Thomson, A. W. & Knolle, P. A. Antigen-presenting cell function in the tolerogenic liver environment. Nat. Rev. Immunol. 10, 753\u2013766 (2010).","journal-title":"Nat. Rev. Immunol."},{"key":"7213_CR5","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1038\/nri3169","volume":"12","author":"U Protzer","year":"2012","unstructured":"Protzer, U., Maini, M. K. & Knolle, P. A. Living in the liver: hepatic infections. Nat. Rev. Immunol. 12, 201\u2013213 (2012).","journal-title":"Nat. Rev. Immunol."},{"key":"7213_CR6","doi-asserted-by":"publisher","first-page":"1193","DOI":"10.1053\/j.gastro.2013.12.036","volume":"146","author":"PA Knolle","year":"2014","unstructured":"Knolle, P. A. & Thimme, R. Hepatic immune regulation and its involvement in viral hepatitis infection. Gastroenterology 146, 1193\u20131207 (2014).","journal-title":"Gastroenterology"},{"key":"7213_CR7","doi-asserted-by":"publisher","first-page":"544","DOI":"10.1111\/j.1478-3231.2011.02682.x","volume":"32","author":"HL Tillmann","year":"2012","unstructured":"Tillmann, H. L., Zachou, K. & Dalekos, G. N. Management of severe acute to fulminant hepatitis B: to treat or not to treat or when to treat? Liver Int. 32, 544\u2013553 (2012).","journal-title":"Liver Int."},{"key":"7213_CR8","doi-asserted-by":"publisher","first-page":"1840","DOI":"10.1038\/sj.leu.2403914","volume":"19","author":"P Niscola","year":"2005","unstructured":"Niscola, P. et al. Fulminant B hepatitis in a surface antigen-negative patient with B-cell chronic lymphocytic leukaemia after rituximab therapy. Leukemia 19, 1840\u20131841 (2005).","journal-title":"Leukemia"},{"key":"7213_CR9","doi-asserted-by":"publisher","first-page":"995","DOI":"10.1016\/S0140-6736(05)62892-9","volume":"349","author":"A Carr","year":"1997","unstructured":"Carr, A. & Cooper, D. A. Restoration of immunity to chronic hepatitis B infection in HIV-infected patient on protease inhibitor. Lancet 349, 995\u2013996 (1997).","journal-title":"Lancet"},{"issue":"Suppl 2","key":"7213_CR10","doi-asserted-by":"publisher","first-page":"S67","DOI":"10.1002\/lt.21612","volume":"14","author":"P Ichai","year":"2008","unstructured":"Ichai, P. & Samuel, D. Etiology and prognosis of fulminant hepatitis in adults. Liver Transplant. 14 (Suppl. 2), S67\u2013S79 (2008).","journal-title":"Liver Transplant."},{"key":"7213_CR11","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1002\/hep.20504","volume":"41","author":"MS Abougergi","year":"2005","unstructured":"Abougergi, M. S., Gidner, S. J., Spady, D. K., Miller, B. C. & Thiele, D. L. Fas and TNFR1, but not cytolytic granule-dependent mechanisms, mediate clearance of murine liver adenoviral infection. Hepatology 41, 97\u2013105 (2005).","journal-title":"Hepatology"},{"key":"7213_CR12","doi-asserted-by":"publisher","first-page":"1588","DOI":"10.4049\/jimmunol.172.3.1588","volume":"172","author":"E Roth","year":"2004","unstructured":"Roth, E. & Pircher, H. IFN-gamma promotes Fas ligand- and perforin-mediated liver cell destruction by cytotoxic CD8 T cells. J. Immunol. 172, 1588\u20131594 (2004).","journal-title":"J. Immunol."},{"key":"7213_CR13","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/S1074-7613(00)80295-2","volume":"4","author":"LG Guidotti","year":"1996","unstructured":"Guidotti, L. G. et al. Intracellular inactivation of the hepatitis B virus by cytotoxic T lymphocytes. Immunity 4, 25\u201336 (1996).","journal-title":"Immunity"},{"key":"7213_CR14","doi-asserted-by":"publisher","first-page":"806","DOI":"10.1038\/364806a0","volume":"364","author":"J Ogasawara","year":"1993","unstructured":"Ogasawara, J. et al. Lethal effect of the anti-Fas antibody in mice. Nature 364, 806\u2013809 (1993).","journal-title":"Nature"},{"key":"7213_CR15","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1016\/j.jhep.2017.04.020","volume":"67","author":"J Fioravanti","year":"2017","unstructured":"Fioravanti, J. et al. Effector CD8+ T cell-derived interleukin-10 enhances acute liver immunopathology. J. Hepatol. 67, 543\u2013548 (2017).","journal-title":"J. Hepatol."},{"key":"7213_CR16","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-017-00387-2","volume":"7","author":"S Tong","year":"2017","unstructured":"Tong, S. et al. Natural killer cell activation contributes to hepatitis B viral control in a mouse model. Sci. Rep. 7, 314 (2017).","journal-title":"Sci. Rep."},{"key":"7213_CR17","doi-asserted-by":"publisher","first-page":"258","DOI":"10.3389\/fimmu.2014.00258","volume":"5","author":"A Schuch","year":"2014","unstructured":"Schuch, A., Hoh, A. & Thimme, R. The role of natural killer cells and CD8(+) T cells in hepatitis B virus infection. Front. Immunol. 5, 258 (2014).","journal-title":"Front. Immunol."},{"key":"7213_CR18","doi-asserted-by":"publisher","first-page":"e49135","DOI":"10.1371\/journal.pone.0049135","volume":"7","author":"J Zhao","year":"2012","unstructured":"Zhao, J. et al. Natural killer cells are characterized by the concomitantly increased interferon-gamma and cytotoxicity in acute resolved hepatitis B patients. PLoS ONE 7, e49135 (2012).","journal-title":"PLoS ONE"},{"key":"7213_CR19","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1111\/j.1478-3231.2004.0982.x","volume":"24","author":"Y Kondo","year":"2004","unstructured":"Kondo, Y. et al. Vigorous response of cytotoxic T lymphocytes associated with systemic activation of CD8 T lymphocytes in fulminant hepatitis B. Liver Int. 24, 561\u2013567 (2004).","journal-title":"Liver Int."},{"key":"7213_CR20","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1016\/S0168-8278(99)80334-1","volume":"31","author":"K Kimura","year":"1999","unstructured":"Kimura, K. et al. Elevated intracellular IFN-gamma levels in circulating CD8+ lymphocytes in patients with fulminant hepatitis. J. Hepatol. 31, 579\u2013583 (1999).","journal-title":"J. Hepatol."},{"key":"7213_CR21","doi-asserted-by":"publisher","first-page":"1938","DOI":"10.1053\/j.gastro.2008.03.037","volume":"134","author":"Z Zhang","year":"2008","unstructured":"Zhang, Z. et al. Dynamic programmed death 1 expression by virus-specific CD8 T cells correlates with the outcome of acute hepatitis B. Gastroenterology 134, 1938\u20131949 (2008).","journal-title":"Gastroenterology"},{"key":"7213_CR22","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1016\/S1369-5274(00)00109-0","volume":"3","author":"A Bertoletti","year":"2000","unstructured":"Bertoletti, A. & Maini, M. K. Protection or damage: a dual role for the virus-specific cytotoxic T lymphocyte response in hepatitis B and C infection? Curr. Opin. Microbiol. 3, 387\u2013392 (2000).","journal-title":"Curr. Opin. Microbiol."},{"key":"7213_CR23","doi-asserted-by":"publisher","first-page":"502","DOI":"10.1016\/j.immuni.2012.11.012","volume":"38","author":"W Kastenmuller","year":"2013","unstructured":"Kastenmuller, W. et al. Peripheral prepositioning and local CXCL9 chemokine-mediated guidance orchestrate rapid memory CD8+ T cell responses in the lymph node. Immunity 38, 502\u2013513 (2013).","journal-title":"Immunity"},{"key":"7213_CR24","doi-asserted-by":"crossref","first-page":"5394","DOI":"10.4049\/jimmunol.157.12.5394","volume":"157","author":"AK Yi","year":"1996","unstructured":"Yi, A. K., Klinman, D. M., Martin, T. L., Matson, S. & Krieg, A. M. Rapid immune activation by CpG motifs in bacterial DNA. Systemic induction of IL-6 transcription through an antioxidant-sensitive pathway. J. Immunol. 157, 5394\u20135402 (1996).","journal-title":"J. Immunol."},{"key":"7213_CR25","doi-asserted-by":"publisher","first-page":"1324","DOI":"10.1038\/nm1663","volume":"13","author":"E Seki","year":"2007","unstructured":"Seki, E. et al. TLR4 enhances TGF-beta signaling and hepatic fibrosis. Nat. Med. 13, 1324\u20131332 (2007).","journal-title":"Nat. Med."},{"key":"7213_CR26","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1034\/j.1600-0528.2002.017411.x","volume":"174","author":"AM Diehl","year":"2000","unstructured":"Diehl, A. M. Cytokine regulation of liver injury and repair. Immunol. Rev. 174, 160\u2013171 (2000).","journal-title":"Immunol. Rev."},{"key":"7213_CR27","doi-asserted-by":"publisher","first-page":"1223","DOI":"10.1084\/jem.182.5.1223","volume":"182","author":"PR Galle","year":"1995","unstructured":"Galle, P. R. et al. Involvement of the CD95 (APO-1\/Fas) receptor and ligand in liver damage. J. Exp. Med. 182, 1223\u20131230 (1995).","journal-title":"J. Exp. Med."},{"key":"7213_CR28","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1038\/nri3839","volume":"15","author":"I Voskoboinik","year":"2015","unstructured":"Voskoboinik, I., Whisstock, J. C. & Trapani, J. A. Perforin and granzymes: function, dysfunction and human pathology. Nat. Rev. Immunol. 15, 388\u2013400 (2015).","journal-title":"Nat. Rev. Immunol."},{"key":"7213_CR29","doi-asserted-by":"publisher","first-page":"2659","DOI":"10.1182\/blood-2012-07-446146","volume":"121","author":"JA Lopez","year":"2013","unstructured":"Lopez, J. A. et al. Perforin forms transient pores on the target cell plasma membrane to facilitate rapid access of granzymes during killer cell attack. Blood 121, 2659\u20132668 (2013).","journal-title":"Blood"},{"key":"7213_CR30","doi-asserted-by":"publisher","first-page":"947","DOI":"10.1111\/febs.13649","volume":"283","author":"VR Sutton","year":"2016","unstructured":"Sutton, V. R. et al. Serglycin determines secretory granule repertoire and regulates natural killer cell and cytotoxic T lymphocyte cytotoxicity. FEBS J. 283, 947\u2013961 (2016).","journal-title":"FEBS J."},{"key":"7213_CR31","doi-asserted-by":"publisher","first-page":"478","DOI":"10.1016\/j.celrep.2012.08.001","volume":"2","author":"D Wohlleber","year":"2012","unstructured":"Wohlleber, D. et al. TNF-induced target cell killing by CTL activated through cross-presentation. Cell Rep. 2, 478\u2013487 (2012).","journal-title":"Cell Rep."},{"key":"7213_CR32","doi-asserted-by":"publisher","first-page":"1977","DOI":"10.1084\/jem.169.6.1977","volume":"169","author":"J Brett","year":"1989","unstructured":"Brett, J. et al. Tumor necrosis factor\/cachectin increases permeability of endothelial cell monolayers by a mechanism involving regulatory G proteins. J. Exp. Med. 169, 1977\u20131991 (1989).","journal-title":"J. Exp. Med."},{"key":"7213_CR33","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1089\/10430340050015941","volume":"11","author":"S Hegenbarth","year":"2000","unstructured":"Hegenbarth, S. et al. Liver sinusoidal endothelial cells are not permissive for adenovirus type 5. Hum. Gene Ther. 11, 481\u2013486 (2000).","journal-title":"Hum. Gene Ther."},{"key":"7213_CR34","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1016\/j.ejmech.2017.05.048","volume":"137","author":"JA Spicer","year":"2017","unstructured":"Spicer, J. A. et al. Substituted arylsulphonamides as inhibitors of perforin-mediated lysis. Eur. J. Med. Chem. 137, 139\u2013155 (2017).","journal-title":"Eur. J. Med. Chem."},{"key":"7213_CR35","doi-asserted-by":"publisher","first-page":"1050","DOI":"10.1016\/j.bmcl.2016.12.057","volume":"27","author":"JA Spicer","year":"2017","unstructured":"Spicer, J. A. et al. Benzenesulphonamide inhibitors of the cytolytic protein perforin. Bioorg. Med. Chem. Lett. 27, 1050\u20131054 (2017).","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"7213_CR36","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1016\/j.cell.2008.01.016","volume":"132","author":"SN Waddington","year":"2008","unstructured":"Waddington, S. N. et al. Adenovirus serotype 5 hexon mediates liver gene transfer. Cell 132, 397\u2013409 (2008).","journal-title":"Cell"},{"key":"7213_CR37","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/j.jhep.2010.10.025","volume":"55","author":"AJ Gehring","year":"2011","unstructured":"Gehring, A. J. et al. Engineering virus-specific T cells that target HBV infected hepatocytes and hepatocellular carcinoma cell lines. J. Hepatol. 55, 103\u2013110 (2011).","journal-title":"J. Hepatol."},{"key":"7213_CR38","doi-asserted-by":"publisher","first-page":"2485","DOI":"10.1084\/jem.20121015","volume":"209","author":"H Frebel","year":"2012","unstructured":"Frebel, H. et al. Programmed death 1 protects from fatal circulatory failure during systemic virus infection of mice. J. Exp. Med. 209, 2485\u20132499 (2012).","journal-title":"J. Exp. Med."},{"key":"7213_CR39","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1172\/JCI115836","volume":"90","author":"G Tiegs","year":"1992","unstructured":"Tiegs, G., Hentschel, J. & Wendel, A. A. T cell-dependent experimental liver injury in mice inducible by concanavalin A. J. Clin. Invest. 90, 196\u2013203 (1992).","journal-title":"J. Clin. Invest."},{"key":"7213_CR40","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1002\/hep.21274","volume":"44","author":"V Schmitz","year":"2006","unstructured":"Schmitz, V. et al. Induction of murine liver damage by overexpression of CD40 ligand provides an experimental model to study fulminant hepatic failure. Hepatology 44, 430\u2013439 (2006).","journal-title":"Hepatology"},{"key":"7213_CR41","doi-asserted-by":"publisher","first-page":"1379","DOI":"10.1093\/infdis\/jit033","volume":"207","author":"BB Andrade","year":"2013","unstructured":"Andrade, B. B. et al. Biomarkers of inflammation and coagulation are associated with mortality and hepatitis flares in persons coinfected with HIV and hepatitis viruses. J. Infect. Dis. 207, 1379\u20131388 (2013).","journal-title":"J. Infect. Dis."},{"key":"7213_CR42","doi-asserted-by":"publisher","DOI":"10.1186\/1742-6405-9-6","volume":"9","author":"A Avihingsanon","year":"2012","unstructured":"Avihingsanon, A. et al. Assessment of HBV flare in a randomized clinical trial in HIV\/HBV coinfected subjects initiating HBV-active antiretroviral therapy in Thailand. AIDS Res. Ther. 9, 6 (2012).","journal-title":"AIDS Res. Ther."},{"key":"7213_CR43","doi-asserted-by":"publisher","first-page":"909","DOI":"10.1002\/hep.23075","volume":"50","author":"A Schurich","year":"2009","unstructured":"Schurich, A. et al. Distinct kinetics and dynamics of cross-presentation in liver sinusoidal endothelial cells compared to dendritic cells. Hepatology 50, 909\u2013919 (2009).","journal-title":"Hepatology"},{"key":"7213_CR44","doi-asserted-by":"publisher","first-page":"1664","DOI":"10.1002\/hep.22795","volume":"49","author":"N von Oppen","year":"2009","unstructured":"von Oppen, N. et al. Systemic antigen cross-presented by liver sinusoidal endothelial cells induces liver-specific CD8 T-cell retention and tolerization. Hepatology 49, 1664\u20131672 (2009).","journal-title":"Hepatology"},{"key":"7213_CR45","doi-asserted-by":"publisher","first-page":"3909","DOI":"10.1073\/pnas.94.8.3909","volume":"94","author":"ML Dustin","year":"1997","unstructured":"Dustin, M. L., Bromley, S. K., Kan, Z., Peterson, D. A. & Unanue, E. R. Antigen receptor engagement delivers a stop signal to migrating T lymphocytes. Proc. Natl Acad. Sci. USA 94, 3909\u20133913 (1997).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"7213_CR46","doi-asserted-by":"publisher","first-page":"1322","DOI":"10.1016\/j.cell.2015.08.004","volume":"162","author":"S Eickhoff","year":"2015","unstructured":"Eickhoff, S. et al. Robust anti-viral immunity requires multiple distinct T cell-dendritic cell interactions. Cell 162, 1322\u20131337 (2015).","journal-title":"Cell"}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-018-07213-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-018-07213-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-018-07213-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,6]],"date-time":"2023-09-06T18:50:17Z","timestamp":1694026217000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-018-07213-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,11,15]]},"references-count":46,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2018,12]]}},"alternative-id":["7213"],"URL":"https:\/\/doi.org\/10.1038\/s41467-018-07213-x","relation":{},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,11,15]]},"assertion":[{"value":"18 October 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 October 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 November 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"4805"}}